Home
Market News
Breaking stock market headlines
Earnings Flash
Breaking coverage of earnings reports, forecasts & dividend updates
Trends
Market movers, trading patterns & key market indicators
Disclosures
Official filings & reports from listed Japanese companies
Explorer
Stock lists filtered by fundamental & technical metrics
Notice of First-Patient-In (FPI) of TMS-007 (JX10) ORION Study Japan Cohort
Non-consolidated Financial Results for the Fiscal Year Ended December 31, 2025 [Japanese GAAP]
Presentation Material for the Fiscal Year Ended December 31, 2025
TMS, loss of 716 Million Yen, Current period performance is undisclosed.
TMS Issues Letter to Shareholders: 2025 Year-in-Review and Strategic Outlook for 2026
Presentation Material for the Six Months Ended August 31, 2025
TMS, Jun-Aug (2Q) Ordinary Profit Loss Narrows
Non-consolidated Financial Results for the Six Months Ended August 31, 2025 [Japanese GAAP]
Notice of Initiation of Analyst Coverage by Pathology Associates
TMS, Mar-May (1Q) Ordinary Profit Loss Widens
Non-consolidated Financial Results for the Three Months Ended May 31, 2025 [Japanese GAAP]
Notice of Administration of TMS-007 (JX10) to the First Subject in the ORION (Phase II/III) Clinical Trial
TMS submits CTN for Phase II/III ORION Study Japan Cohort of JX10 to PMDA
TMS, Last Fiscal Year's Ordinary Profit Loss Narrows, Current period performance is undisclosed.
Presentation Material for the Fiscal Year Ended February 28,2025
Non-consolidated Financial Results for the Fiscal Year Ended February 28, 2025 [Japanese GAAP]
Notice of TMS-008 Phase I First Data Readout
Notice Regarding the Exercise Price Payment of the 10th Share Acquisition Rights (with Moving Strike Warrant) by Third-Party Allotment
[Delayed]Notice Regarding the Issuance of the 10th Series of Stock Acquisition Rights (with Moving Strike Warrant) by Third-Party Allotment
Notice of Royalty and Compensation Payment